Stryker today announced that it is to invest over €200m in Research, Development and Innovation (RD&I) projects at three of its five Cork facilities.
The company aims to expand products and services across its Medical Surgical, Orthopaedics and Neurotechnology and Spine offerings. The RD&I projects are supported by the Irish Government through IDA Ireland. Last year, Stryker invested more than 6% of its global sales into research and development.
Welcoming the news today, Minister for Business, Enterprise & Innovation, Heather Humphreys said, "I am delighted to see this substantial investment from Stryker at their sites in Cork. This not only reflects the company’s commitment to Ireland, it is also a testament to our talented workforce. These RD&I projects are truly world leading, highly innovative and pioneering. Without a doubt, they have the potential to change the face of healthcare provision, reaffirming Ireland’s position as a global leader in the MedTech industry."
IDA Ireland Executive Director, Mary Buckley added, "Stryker is a major and valued employer in Cork, Limerick and the wider South region. This projects further embeds Stryker, offers exciting and challenging opportunities to best in class researchers, and positions Cork at the forefront of MedTech innovation."